Vitamin D supplementation in women does not affect cancer rates in postmenopausal women, although the results of a recent study suggest more research is needed. In a four-year study from Nebraska, 2,303 healthy postmenopausal women were randomized to vitamin D3 2,000 IU/day along with calcium 1,500 mg/day or matching placebo. Vitamin D treatment raised serum levels from an average of 32.8 ng/mL to 43.9 ng/mL in the treatment group. A new cancer diagnosis was confirmed in 45 participants in the vitamin D/calcium group (3.89%) and 64 (5.58%) in the placebo group (difference, 1.69%; 95% CI, -0.06% to 3.46%; P = 0 .06), a nonsignificant difference. There were more kidney stones in the treatment group. The authors concluded that vitamin D plus calcium did not reduce cancer rates significantly, but more research is needed. (JAMA 2017;317:1234-1243)
Investigators determined vitamin D plus calcium did not reduce cancer rates significantly, but more research is needed.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content